English 
     
   首 页
   热点信息
学生工作办公室简介
联系我们
语言中心主任致辞
培养方案
专业介绍
招生问答
请加QQ群312279505
刘庄教授课题组与苏大医学部杨凯副教授课题组合作在Small上发表论文
发布时间:2017-06-21 点击:1003

题目:

Albumin-Templated Manganese Dioxide Nanoparticles for Enhanced Radioisotope Therapy

 

 

作者:

Longlong Tian1, Qian Chen1, Xuan Yi2, Jiawen Chen1, Chao Liang1, Yu Chao1, Kai Yang,*2and Zhuang Liu*1

 

 

单位:

 

1Institute of Functional Nano & Soft Materials Laboratory (FUNSOM), Collaborative Innovation Center of Suzhou, Nano Science and Technology, Soochow University, Suzhou, Jiangsu 215123, China

2School of Radiation Medicine and Protection & School for Radiological and Interdisciplinary Sciences (RAD-X), Jiangsu Provincial Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, Jiangsu 215123, China

 

 

 

摘要:      

Although nanoparticle-based drug delivery systems have been widely explored for tumor-targeted delivery of radioisotope therapy (RIT), the hypoxia zones of tumors on one hand can hardly be reached by nanoparticles with relatively large sizes due to their limited intratumoral diffusion ability, on the other hand often exhibit hypoxiaassociated resistance to radiation-induced cell damage. To improve RIT treatment of solid tumors, herein, radionuclide 131I labeled human serum albumin (HSA)-bound manganese dioxide nanoparticles (131I-HSA-MnO2) are developed as a novel RIT nanomedicine platform that is responsive to the tumor microenvironment (TME).Such 131I-HSA-MnO2 nanoparticles with suitable sizes during blood circulation show rather efficient tumor passive uptake owing to the enhanced permeability and retention effect, as well as little retention in other normal organs to minimize radiotoxicity. The acidic TME can trigger gradual degradation of MnO2 and thus decomposition of 131I-HSA-MnO2 nanoparticles into individual 131I-HSA withsub-10 nm sizes and greatly improves intratumoral diffusion. Furthermore, oxygen produced by MnO2-triggered decomposition of tumor endogenous H2O2 would be helpful to relieve hypoxia-associated RIT resistant for those tumors. As the results, the 131I-HSA-MnO2 nanoparticles appear to be a highly effective RIT agent showing great efficacy in tumor treatment upon systemic administration.

 

 

影响因子:

8.643

 

 

分区情况:

1

 

 

链接:

http://onlinelibrary.wiley.com/doi/10.1002/smll.201700640/full

 

 

责任编辑:向丹婷 联系方式:dtxiang@suda.edu.cn

 


Copyright © 2012 苏州大学纳米科学技术学院 All Rights Reserved.
  地址:苏州工业园区仁爱路199号910楼  邮编:215123
您是第 位访问者